Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A peptide corresponding to amino acids 840 - 900 of human LGR6. The Lgr6 Blocking Peptide is derived from Synthetic. The Lgr6 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-053142 |
| Réf. fabricant | 18235263 |
| Gene ID (Entrez) | 59352 |
| Espèces | Human |
| Pureté | >85%, by HPLC |
| Numéro d’adhésion | CAI15929 |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-49695. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | FLJ14471, gonadotropin receptor, GPCR, leucine-rich repeat containing G protein-coupled receptor 6, leucine-rich repeat-containing G protein-coupled receptor 6, leucine-rich repeat-containing G-protein coupled receptor 6, VTS20631 |
| Symbole de gène(s) | LGR6 |
| Type de produit | Lgr6 |
| Quantité | 0.25 mg |
| État réglementaire | RUO - research use only |
| Consigne | Synthetic peptides corresponding to unique epitope on Lgr6 The peptide sequence corresponding to amino acids 860-915 of the human Lgr6 protein, the peptide was post-synthetically modified to achieve desired antigenicity before coupling to a carrier prot |
